KBC Group Portfolio holdings
KBC Group is a Belgian bank and insurer, created in 1998 when the banks Kredietbank and CERA Bank merged with the insurers ABB and Fidelitas. It serves private clients and small and medium-sized businesses in Belgium, Bulgaria, the Czech Republic, Hungary and Slovakia, selling banking and insurance side by side. Its push into Central and Eastern Europe began in 1999 with the purchase of ČSOB, a bank serving the Czech Republic and Slovakia. In 2005 the holding company formed in the 1998 merger combined with its parent, Almanij, to become KBC Group, which added a network of European private banks. Among its main shareholders is KBC Ancora, a listed company controlled by Cera, the holding company set up by CERA Bank's cooperative clients at the time of the 1998 merger.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$207M |
| 2 |
Walmart Inc
WMT
|
+$203M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$168M |
| 4 |
Tesla
TSLA
|
+$153M |
| 5 |
Palo Alto Networks
PANW
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$261M |
| 2 |
NVIDIA
NVDA
|
+$252M |
| 3 |
Lam Research
LRCX
|
+$237M |
| 4 |
Apple
AAPL
|
+$228M |
| 5 |
UnitedHealth
UNH
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.73% |
| 2 | Financials | 11.85% |
| 3 | Communication Services | 11.01% |
| 4 | Healthcare | 10.37% |
| 5 | Consumer Discretionary | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1226
Redwire
RDW
$1.93B
| $134K | ﹤0.01% |
12,832
+5,161
| +67% | +$55.7K |
2026 Q1
2 quarters
|
|
1227
Core Scientific
CORZ
$4.68B
| $133K | ﹤0.01% |
8,300
| – | – |
2024 Q4
7 quarters
|
|
1228
ICU Medical
ICUI
$4.48B
| $133K | ﹤0.01% |
829
| – | – |
2023 Q3
12 quarters
|
|
1229
Construction Partners
ROAD
$4.58B
| $133K | ﹤0.01% |
1,477
| – | – |
2023 Q4
11 quarters
|
|
1230
Synaptics
SYNA
$4.69B
| $133K | ﹤0.01% |
1,315
| – | – |
2023 Q3
12 quarters
|
|
1231
Valvoline
VVV
$4.42B
| $133K | ﹤0.01% |
4,403
+1,169
| +36% | +$40.1K |
2023 Q3
12 quarters
|
|
1232
Cabot Corp
CBT
$3.69B
| $132K | ﹤0.01% |
1,712
| – | – |
2023 Q3
12 quarters
|
|
1233
CG Oncology
CGON
$6.65B
| $132K | ﹤0.01% |
1,862
+709
| +61% | +$52.1K |
2026 Q1
2 quarters
|
|
1234
CareDx
CDNA
$4.09B
| $131K | ﹤0.01% |
2,018
| – | – |
2024 Q3
8 quarters
|
|
1235
Columbia Financial
CLBK
$3.01B
| $131K | ﹤0.01% |
+11,809
| New | +$130K |
2026 Q3
0 quarters
|
|
1236
PJT Partners
PJT
$3.81B
| $131K | ﹤0.01% |
918
| – | – |
2024 Q2
9 quarters
|
|
1237
Virtu Financial
VIRT
$5.26B
| $131K | ﹤0.01% |
2,377
| – | – |
2024 Q2
9 quarters
|
|
1238
Cathay General Bancorp
CATY
$4.33B
| $130K | ﹤0.01% |
2,191
| – | – |
2023 Q3
12 quarters
|
|
1239
M/I Homes
MHO
$3.21B
| $130K | ﹤0.01% |
965
| – | – |
2022 Q2
17 quarters
|
|
1240
ONE Gas
OGS
$5.27B
| $130K | ﹤0.01% |
1,809
| – | – |
2023 Q3
12 quarters
|
|
1241
Amneal Pharmaceuticals
AMRX
$7.45B
| $129K | ﹤0.01% |
6,417
| – | – |
2026 Q1
2 quarters
|
|
1242
Avient
AVNT
$4.1B
| $129K | ﹤0.01% |
3,215
| – | – |
2023 Q3
12 quarters
|
|
1243
COPT Defense Properties
CDP
$3.76B
| $129K | ﹤0.01% |
3,862
| – | – |
2023 Q3
12 quarters
|
|
1244
Lifestance Health
LFST
$5.35B
| $129K | ﹤0.01% |
10,701
+6,178
| +137% | +$72.9K |
2026 Q1
2 quarters
|
|
1245
Texas Capital Bancshares, Inc. Common Stock, par value $0.01 per share
TXCP
$4.35B
| $129K | ﹤0.01% |
1,383
| – | – |
2023 Q3
12 quarters
|
|
1246
Trex
TREX
$5.27B
| $129K | ﹤0.01% |
2,956
| – | – |
2022 Q4
15 quarters
|
|
1247
Veracyte
VCYT
$1.96B
| $129K | ﹤0.01% |
2,802
| – | – |
2023 Q3
12 quarters
|
|
1248
Viking Therapeutics
VKTX
$3.73B
| $129K | ﹤0.01% |
3,960
| – | – |
2024 Q1
10 quarters
|
|
1249
Caris Life Sciences
CAI
$6.61B
| $129K | ﹤0.01% |
+4,221
| New | +$94.8K |
2026 Q3
0 quarters
|
|
1250
Boot Barn
BOOT
$4.12B
| $128K | ﹤0.01% |
1,064
| – | – |
2022 Q1
18 quarters
|
|
Similar funds
KBC Group's Q3 2026 Portfolio in Review
As of Q3 2026, KBC Group held 1,901 positions worth $47.9B, up 3.4% from $46.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
KBC Group's Q3 2026 filing shows 57 new, 602 increased, 322 reduced and 75 closed positions. Its largest new stake was News Corp Class B: 24,514 shares worth $778K. The largest sale was JPMorgan Chase, an estimated $261M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 40% a quarter earlier, followed by Financials and Communication Services.
- KBC Group's largest Q3 2026 buy was News Corp Class B: 24,514 shares worth $778K.
- KBC Group added most to Advanced Micro Devices in Q3 2026, an estimated $207M increase.
- KBC Group's biggest Q3 2026 reduction was JPMorgan Chase, cutting an estimated $261M.
- KBC Group fully exited Electronic Arts in Q3 2026, selling an estimated $67.9M.
- KBC Group's ten largest holdings make up 38% of its $47.9B portfolio in Q3 2026.
- KBC Group opened 57 new positions and closed 75 in Q3 2026.
- KBC Group's portfolio value rose 3.4% quarter-over-quarter to $47.9B.
Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.